These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25498779)

  • 1. Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening.
    Kilambi V; Johnson FR; González JM; Mohamed AF
    Value Health; 2014 Dec; 17(8):838-45. PubMed ID: 25498779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferences for genetic testing for colorectal cancer within a population-based screening program: a discrete choice experiment.
    Veldwijk J; Lambooij MS; Kallenberg FG; van Kranen HJ; Bredenoord AL; Dekker E; Smit HA; de Wit GA
    Eur J Hum Genet; 2016 Mar; 24(3):361-6. PubMed ID: 26036860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.
    Benning TM; Dellaert BG; Severens JL; Dirksen CD
    Value Health; 2014 Jul; 17(5):578-87. PubMed ID: 25128051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
    Newton K; Green K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eliciting population preferences for mass colorectal cancer screening organization.
    Nayaradou M; Berchi C; Dejardin O; Launoy G
    Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of screening strategies for Lynch syndrome.
    Barzi A; Sadeghi S; Kattan MW; Meropol NJ
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer Screening: Preferences, Past Behavior, and Future Intentions.
    Mansfield C; Ekwueme DU; Tangka FKL; Brown DS; Smith JL; Guy GP; Li C; Hauber B
    Patient; 2018 Dec; 11(6):599-611. PubMed ID: 29740804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.
    Hadley DW; Jenkins JF; Steinberg SM; Liewehr D; Moller S; Martin JC; Calzone KA; Soballe PW; Kirsch IR
    J Clin Oncol; 2008 Feb; 26(6):948-54. PubMed ID: 18281669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumour examination to detect hereditary colorectal cancer].
    Hoogerbrugge N; Hermens RP; Nagengast F; Overbeek L; van Krieken HJ; Ligtenberg M
    Ned Tijdschr Geneeskd; 2012; 156(42):A4982. PubMed ID: 23075775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.
    Engel C; Rahner N; Schulmann K; Holinski-Feder E; Goecke TO; Schackert HK; Kloor M; Steinke V; Vogelsang H; Möslein G; Görgens H; Dechant S; von Knebel Doeberitz M; Rüschoff J; Friedrichs N; Büttner R; Loeffler M; Propping P; Schmiegel W;
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):174-82. PubMed ID: 19835992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
    Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
    Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient mismatch repair testing in colorectal cancer: more than just screening for Lynch syndrome.
    West NP
    Colorectal Dis; 2019 Jun; 21(6):621-622. PubMed ID: 31152577
    [No Abstract]   [Full Text] [Related]  

  • 18. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
    Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
    Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
    Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening.
    de Bekker-Grob EW; Hol L; Donkers B; van Dam L; Habbema JD; van Leerdam ME; Kuipers EJ; Essink-Bot ML; Steyerberg EW
    Value Health; 2010; 13(2):315-23. PubMed ID: 19912597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.